Effect of L-Dihydroxyphenylserine (L-DOPS) on Falls in Patients With Neurogenic Orthostatic Hypotension (NOH)
Status:
Unknown status
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
This will be a Phase II single center, double-blind, randomized, placebo-controlled, efficacy
study. Subjects will complete six visits. The first will be a screening visit. There will be
four assessment visits: baseline, 2 weeks after the double-blinded trial begins, the end of
the blinded trial, and after 4 weeks of washout. There will also be an additional
randomization and medication dispensing visit immediately following the dose optimization
period and preceding the double-blinded trial.